{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:20:17Z","timestamp":1787678417566,"version":"build-2784847793"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05601-9","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:02:54Z","timestamp":1714521774000},"page":"1607-1619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Axial Spondyloarthritis: an overview of the disease"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0441-3043","authenticated-orcid":false,"given":"Mariana","family":"Ivanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9750-4406","authenticated-orcid":false,"given":"Ivan","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-9478","authenticated-orcid":false,"given":"Alexander K.","family":"Angelov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-4648","authenticated-orcid":false,"given":"Tsvetoslav","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"issue":"10089","key":"5601_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D (2017) Axial spondyloarthritis. Lancet 390(10089):73\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(16)31591-4","journal-title":"Lancet"},{"issue":"12","key":"5601_CR2","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, El-Zorkany B, van der Heijde D (2021) Axial spondyloarthritis. Ann Rheum Dis 80(12):1511\u20131521. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221035","journal-title":"Ann Rheum Dis"},{"issue":"7809","key":"5601_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/s0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1(7809):904\u2013907. https:\/\/doi.org\/10.1016\/s0140-6736(73)91360-3","journal-title":"Lancet"},{"issue":"14","key":"5601_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJM197304052881403","volume":"288","author":"L Schlosstein","year":"1973","unstructured":"Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288(14):704\u2013706. https:\/\/doi.org\/10.1056\/NEJM197304052881403","journal-title":"N Engl J Med"},{"issue":"4","key":"5601_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/ard.55.4.268","volume":"55","author":"MA Brown","year":"1996","unstructured":"Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, Wordsworth BP, Corn\u00e9lis F (1996) HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 55(4):268\u2013270. https:\/\/doi.org\/10.1136\/ard.55.4.268","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5601_CR6","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34(10):1218\u20131227. https:\/\/doi.org\/10.1002\/art.1780341003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5601_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, S\u00f8rensen IJ, Valle-O\u00f1ate R, Weber U, Wei J, Sieper J (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5601_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.20990","volume":"52","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52(4):1000\u20131008. https:\/\/doi.org\/10.1002\/art.20990","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5601_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, S\u00f8rensen IJ, Ozgocmen S, Roussou E, Valle-O\u00f1ate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5601_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, G\u00e9her P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Comp\u00e0n V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978\u2013991. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210770","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5601_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"issue":"2","key":"5601_CR12","first-page":"85","volume":"57","author":"B Amor","year":"1990","unstructured":"Amor B, Dougados M, Mijiyawa M (1990) Crit\u00e8res de classification des spondylarthropathies [Criteria of the classification of spondylarthropathies]. Rev Rhum Mal Osteoartic 57(2):85\u201389","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"2","key":"5601_CR13","first-page":"246","volume":"22","author":"E Collantes-Estevez","year":"1995","unstructured":"Collantes-Estevez E, Cisnal del Mazo A, Mu\u00f1oz-Gomariz E (1995) Assessment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by a Spanish multicenter study. European Spondyloarthropathy Study Group. J Rheumatol 22(2):246\u2013251","journal-title":"J Rheumatol"},{"key":"5601_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1148\/radiology.194.2.7824736","volume":"194","author":"M Bollow","year":"1995","unstructured":"Bollow M, Braun J, Hamm B, Eggens U, Schilling A, K\u00f6nig H, Wolf KJ (1995) Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging. Radiology 194:529\u2013536. https:\/\/doi.org\/10.1148\/radiology.194.2.7824736","journal-title":"Radiology"},{"issue":"7","key":"5601_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780370709","volume":"37","author":"J Braun","year":"1994","unstructured":"Braun J, Bollow M, Eggens U, K\u00f6nig H, Distler A, Sieper J (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 37(7):1039\u20131045. https:\/\/doi.org\/10.1002\/art.1780370709","journal-title":"Arthritis Rheum"},{"issue":"8","key":"5601_CR16","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5601_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"key":"5601_CR18","first-page":"326","volume-title":"The epidemiology of chronic rheumatism","author":"JH Kellgren","year":"1963","unstructured":"Kellgren JH, Jeffrey MR, Ball J (1963) The epidemiology of chronic rheumatism, vol I. Blackwell, Oxford, pp 326\u2013327"},{"issue":"4","key":"5601_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/ard.32.4.354","volume":"32","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V (1973) New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis 32(4):354\u2013363. https:\/\/doi.org\/10.1136\/ard.32.4.354","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5601_CR20","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1002\/art.24024","volume":"58","author":"AN Bennett","year":"2008","unstructured":"Bennett AN, McGonagle D, O\u2019Connor P, Hensor EM, Sivera F, Coates LC, Emery P, Marzo-Ortega H (2008) Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58(11):3413\u20133418. https:\/\/doi.org\/10.1002\/art.24024","journal-title":"Arthritis Rheum"},{"issue":"2","key":"5601_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF02203386","volume":"6","author":"W Mau","year":"1987","unstructured":"Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Deicher H (1987) Outcome of possible ankylosing spondylitis in a 10 years\u2019 follow-up study. Clin Rheumatol 6(2):60\u201366. https:\/\/doi.org\/10.1007\/BF02203386","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5601_CR22","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s10067-022-06100-7","volume":"41","author":"CA Hay","year":"2022","unstructured":"Hay CA, Packham J, Ryan S, Mallen CD, Chatzixenitidis A, Prior JA (2022) Diagnostic delay in axial spondyloarthritis: a systematic review. Clin Rheumatol 41(7):1939\u20131950. https:\/\/doi.org\/10.1007\/s10067-022-06100-7","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5601_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5606\/ArchRheumatol.2016.5562","volume":"31","author":"S Fallahi","year":"2016","unstructured":"Fallahi S, Jamshidi AR (2016) Diagnostic delay in ankylosing spondylitis: related factors and prognostic outcomes. Arch Rheumatol 31(1):24\u201330. https:\/\/doi.org\/10.5606\/ArchRheumatol.2016.5562","journal-title":"Arch Rheumatol"},{"key":"5601_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.rdc.2012.04.007","volume":"38","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Rudwaleit M (2012) Early spondyloarthritis. Rheum Dis Clin North Am 38:387\u2013403. https:\/\/doi.org\/10.1016\/j.rdc.2012.04.007","journal-title":"Rheum Dis Clin North Am"},{"key":"5601_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4078\/jrd.2021.28.2.55","volume":"28","author":"RD Inman","year":"2021","unstructured":"Inman RD (2021) Axial spondyloarthritis: current advances, future challenges. J Rheum Dis 28:55\u201359. https:\/\/doi.org\/10.4078\/jrd.2021.28.2.55","journal-title":"J Rheum Dis"},{"issue":"8872","key":"5601_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0140-6736(93)91760-j","volume":"342","author":"E Hermann","year":"1993","unstructured":"Hermann E, Yu DT, Meyer-zum-B\u00fcschenfelde KH, Fleischer B (1993) HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342(8872):646\u2013650. https:\/\/doi.org\/10.1016\/0140-6736(93)91760-j","journal-title":"Lancet"},{"issue":"5","key":"5601_CR27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345(5):340\u2013350. https:\/\/doi.org\/10.1056\/NEJM200108023450506","journal-title":"N Engl J Med"},{"issue":"7","key":"5601_CR28","first-page":"266","volume":"60","author":"JG Damoiseaux","year":"2002","unstructured":"Damoiseaux JG, Tervaert JW (2002) The definition of autoimmune disease: are Koch\u2019s postulates applicable? Neth J Med 60(7):266\u2013268","journal-title":"Neth J Med"},{"issue":"8","key":"5601_CR29","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLoS Med 3(8):e297. https:\/\/doi.org\/10.1371\/journal.pmed.0030297","journal-title":"PLoS Med"},{"issue":"9","key":"5601_CR30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.autrev.2018.04.002","volume":"17","author":"E Generali","year":"2018","unstructured":"Generali E, Bose T, Selmi C, Voncken JW, Damoiseaux JGMC (2018) Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory. Autoimmun Rev 17(9):935\u2013941. https:\/\/doi.org\/10.1016\/j.autrev.2018.04.002","journal-title":"Autoimmun Rev"},{"issue":"4","key":"5601_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/09273948.2016.1175641","volume":"24","author":"CH Sibley","year":"2016","unstructured":"Sibley CH (2016) Autoinflammation and HLA-B27: beyond antigen presentation. Ocul Immunol Inflamm 24(4):460\u2013469. https:\/\/doi.org\/10.1080\/09273948.2016.1175641","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"5601_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4161\/pri.3.1.8072","volume":"3","author":"RA Colbert","year":"2009","unstructured":"Colbert RA, DeLay ML, Layh-Schmitt G, Sowders DP (2009) HLA-B27 misfolding and spondyloarthropathies. Prion 3(1):15\u201326. https:\/\/doi.org\/10.4161\/pri.3.1.8072","journal-title":"Prion"},{"key":"5601_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-1-4419-0298-6_19","volume":"649","author":"MT Fiorillo","year":"2009","unstructured":"Fiorillo MT, Sorrentino R (2009) T-cell responses against viral and self-epitopes and HLA-B27 subtypes differentially associated with ankylosing spondylitis. Adv Exp Med Biol 649:255\u2013262. https:\/\/doi.org\/10.1007\/978-1-4419-0298-6_19","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"5601_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.autrev.2009.01.003","volume":"8","author":"A Mathieu","year":"2009","unstructured":"Mathieu A, Paladini F, Vacca A, Cauli A, Fiorillo MT, Sorrentino R (2009) The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun Rev 8(5):420\u2013425. https:\/\/doi.org\/10.1016\/j.autrev.2009.01.003","journal-title":"Autoimmun Rev"},{"issue":"10","key":"5601_CR35","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1128\/iai.65.10.4236-4242.1997","volume":"65","author":"M Virtala","year":"1997","unstructured":"Virtala M, Kirveskari J, Granfors K (1997) HLA-B27 modulates the survival of Salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production. Infect Immun 65(10):4236\u20134242. https:\/\/doi.org\/10.1128\/iai.65.10.4236-4242.1997","journal-title":"Infect Immun"},{"issue":"1","key":"5601_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2006.10.004","volume":"108","author":"JA L\u00f3pez de Castro","year":"2007","unstructured":"L\u00f3pez de Castro JA (2007) HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 108(1):27\u201333. https:\/\/doi.org\/10.1016\/j.imlet.2006.10.004","journal-title":"Immunol Lett"},{"issue":"4","key":"5601_CR37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/art.39515","volume":"68","author":"A Ridley","year":"2016","unstructured":"Ridley A, Hatano H, Wong-Baeza I, Shaw J, Matthews KK, Al-Mossawi H, Ladell K, Price DA, Bowness P, Kollnberger S (2016) Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis. Arthritis Rheumatol 68(4):901\u2013914. https:\/\/doi.org\/10.1002\/art.39515","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"5601_CR38","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.4049\/jimmunol.1202926","volume":"190","author":"I Wong-Baeza","year":"2013","unstructured":"Wong-Baeza I, Ridley A, Shaw J, Hatano H, Rysnik O, McHugh K, Piper C, Brackenbridge S, Fernandes R, Chan A, Bowness P, Kollnberger S (2013) KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis. J Immunol 190(7):3216\u20133224. https:\/\/doi.org\/10.4049\/jimmunol.1202926","journal-title":"J Immunol"},{"issue":"11","key":"5601_CR39","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1002\/art.21395","volume":"52","author":"AT Chan","year":"2005","unstructured":"Chan AT, Kollnberger SD, Wedderburn LR, Bowness P (2005) Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum 52(11):3586\u20133595. https:\/\/doi.org\/10.1002\/art.21395","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5601_CR40","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","volume":"186","author":"P Bowness","year":"2011","unstructured":"Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, Fleming M, Cummings F, McMichael A, Kollnberger S (2011) Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 186(4):2672\u20132680. https:\/\/doi.org\/10.4049\/jimmunol.1002653","journal-title":"J Immunol"},{"issue":"7","key":"5601_CR41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"International Genetics of Ankylosing Spondylitis Consortium (IGAS), Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, Cremin K, Pryce K, Harris J, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, F\u00f8rre \u00d8, Tuomilehto J, Laiho K, Jiang L, Liu Y, Wu X, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Kenna TJ, Haroon N, Ferreira MA, Yang J, Mulero J, Fernandez-Sueiro JL, Gonzalez-Gay MA, Lopez-Larrea C, Deloukas P et al (2013) Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 45(7):730\u2013738. https:\/\/doi.org\/10.1038\/ng.2667","journal-title":"Nat Genet"},{"issue":"7","key":"5601_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni1208","volume":"6","author":"L Saveanu","year":"2005","unstructured":"Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, Lepelletier Y, Greer F, Schomburg L, Fruci D, Niedermann G, van Endert PM (2005) Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 6(7):689\u2013697. https:\/\/doi.org\/10.1038\/ni1208","journal-title":"Nat Immunol"},{"issue":"11","key":"5601_CR43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"PR Burton","year":"2007","unstructured":"Burton PR, Clayton DG, Cardon LR et al (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39(11):1329\u20131337. https:\/\/doi.org\/10.1038\/ng.2007.17","journal-title":"Nat Genet"},{"issue":"1","key":"5601_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","volume":"18","author":"JJ de Winter","year":"2016","unstructured":"de Winter JJ, van Mens LJ, van der Heijde D, Landew\u00e9 R, Baeten DL (2016) Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther 18(1):196. https:\/\/doi.org\/10.1186\/s13075-016-1093-z","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"5601_CR45","first-page":"2273","volume":"22","author":"H Mielants","year":"1995","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Elewaut D (1995) The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 22(12):2273\u20132278","journal-title":"J Rheumatol"},{"key":"5601_CR46","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","volume":"110","author":"M De Vos","year":"1996","unstructured":"De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E (1996) Long term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 110:1696\u20131703. https:\/\/doi.org\/10.1053\/gast.1996.v110.pm8964393","journal-title":"Gastroenterology"},{"issue":"8","key":"5601_CR47","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.autrev.2014.04.003","volume":"13","author":"I Olivieri","year":"2014","unstructured":"Olivieri I, Cantini F, Castiglione F, Felice C, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Armuzzi A (2014) Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev 13(8):822\u2013830. https:\/\/doi.org\/10.1016\/j.autrev.2014.04.003","journal-title":"Autoimmun Rev"},{"issue":"7","key":"5601_CR48","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrrheum.2016.85","volume":"12","author":"T Van de Wiele","year":"2016","unstructured":"Van de Wiele T, Van Praet JT, Marzorati M, Drennan MB, Elewaut D (2016) How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol 12(7):398\u2013411. https:\/\/doi.org\/10.1038\/nrrheum.2016.85","journal-title":"Nat Rev Rheumatol"},{"key":"5601_CR49","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.38967","volume":"67","author":"ME Costello","year":"2015","unstructured":"Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, Marshall M, Kenna TJ, Triolo G, Brown MA (2015) Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol 67:686\u2013691. https:\/\/doi.org\/10.1002\/art.38967","journal-title":"Arthritis Rheumatol"},{"key":"5601_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/art.39802","volume":"69","author":"RY Tito","year":"2017","unstructured":"Tito RY, Cypers H, Joossens M, Varkas G, Van Praet L, Glorieus E, Van den Bosch F, De Vos M, Raes J, Elewaut D (2017) Brief report: dialister as a microbial marker of disease activity in spondyloarthritis. Arthritis Rheumatol 69:114\u2013121. https:\/\/doi.org\/10.1002\/art.39802","journal-title":"Arthritis Rheumatol"},{"key":"5601_CR51","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","volume":"76","author":"M Breban","year":"2017","unstructured":"Breban M, Tap J, Leboime A, Said-Nahal R, Langella P, Chiocchia G, Furet JP, Sokol H (2017) Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann Rheum Dis 76:1614\u20131622. https:\/\/doi.org\/10.1136\/annrheumdis-2016-211064","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5601_CR52","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3390\/children9040569","volume":"9","author":"ML Stoll","year":"2022","unstructured":"Stoll ML, DeQuattro K, Li Z, Sawhney H, Weiss PF, Nigrovic PA, Wright TB, Schikler K, Edelheit B, Morrow CD, Reveille JD, Brown MA, Gensler LS (2022) Impact of HLA-B27 and disease status on the gut microbiome of the offspring of ankylosing spondylitis patients. Children (Basel) 9(4):569. https:\/\/doi.org\/10.3390\/children9040569","journal-title":"Children (Basel)"},{"key":"5601_CR53","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fmicb.2018.00432","volume":"9","author":"MC Opazo","year":"2018","unstructured":"Opazo MC, Ortega-Rocha EM, Coronado-Arr\u00e1zola I, Bonifaz LC, Boudin H, Neunlist M, Bueno SM, Kalergis AM, Riedel CA (2018) Intestinal microbiota influences non-intestinal related autoimmune diseases. Front Microbiol 9:432. https:\/\/doi.org\/10.3389\/fmicb.2018.00432","journal-title":"Front Microbiol"},{"key":"5601_CR54","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3389\/fmicb.2017.02696","volume":"8","author":"A Picchianti-Diamanti","year":"2018","unstructured":"Picchianti-Diamanti A, Rosado MM, D\u2019Amelio R (2018) Infectious agents and inflammation: the role of microbiota in autoimmune arthritis. Front Microbiol 8:2696. https:\/\/doi.org\/10.3389\/fmicb.2017.02696","journal-title":"Front Microbiol"},{"issue":"3","key":"5601_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101897","volume":"37","author":"MGH van de Sande","year":"2023","unstructured":"van de Sande MGH, Elewaut D (2023) Pathophysiology and immunolgical basis of axial spondyloarthritis. Best Pract Res Clin Rheumatol 37(3):101897. https:\/\/doi.org\/10.1016\/j.berh.2023.101897","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"5601_CR56","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/ar4228","volume":"15","author":"ME Costello","year":"2013","unstructured":"Costello ME, Elewaut D, Kenna TJ, Brown MA (2013) Microbes, the gut and ankylosing spondylitis. Arthritis Res Ther 15(3):214. https:\/\/doi.org\/10.1186\/ar4228","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"5601_CR57","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.2854","volume":"18","author":"RJ Lories","year":"2012","unstructured":"Lories RJ, McInnes IB (2012) Primed for inflammation: enthesis-resident T cells. Nat Med 18(7):1018\u20131019. https:\/\/doi.org\/10.1038\/nm.2854","journal-title":"Nat Med"},{"issue":"2","key":"5601_CR58","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.clim.2015.05.001","volume":"159","author":"ML Stoll","year":"2015","unstructured":"Stoll ML (2015) Gut microbes, immunity, and spondyloarthritis. Clin Immunol 159(2):134\u2013142. https:\/\/doi.org\/10.1016\/j.clim.2015.05.001","journal-title":"Clin Immunol"},{"issue":"12","key":"5601_CR59","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/ard.2007.070243","volume":"66","author":"I Eshed","year":"2007","unstructured":"Eshed I, Bollow M, McGonagle DG, Tan AL, Althoff CE, Asbach P, Hermann KG (2007) MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis 66(12):1553\u20131559. https:\/\/doi.org\/10.1136\/ard.2007.070243","journal-title":"Ann Rheum Dis"},{"key":"5601_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11926-018-0751-3","volume":"20","author":"A Watad","year":"2018","unstructured":"Watad A, Cuthbert RJ, Amital H, McGonagle D (2018) Enthesitis: much more than focal insertion point inflammation. Curr Rheumatol Rep 20:41. https:\/\/doi.org\/10.1007\/s11926-018-0751-3","journal-title":"Curr Rheumatol Rep"},{"issue":"Pt 5","key":"5601_CR61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1046\/j.1469-7580.2001.19950503.x","volume":"199","author":"M Benjamin","year":"2001","unstructured":"Benjamin M, McGonagle D (2001) The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 199(Pt 5):503\u2013526. https:\/\/doi.org\/10.1046\/j.1469-7580.2001.19950503.x","journal-title":"J Anat"},{"key":"5601_CR62","first-page":"2155","volume":"28","author":"D McGonagle","year":"2001","unstructured":"McGonagle D, Stockwin L, Isaacs J, Emery P (2001) An enthesitis based model for the pathogenesis of spondyloarthropathy. Additive effects of microbial adjuvant and biomechanical factors at disease sites. J Rheumatol 28:2155\u20132159","journal-title":"J Rheumatol"},{"issue":"4","key":"5601_CR63","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/ard.60.4.316","volume":"60","author":"L Laloux","year":"2001","unstructured":"Laloux L, Voisin MC, Allain J, Martin N, Kerboull L, Chevalier X, Claudepierre P (2001) Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 60(4):316\u2013321. https:\/\/doi.org\/10.1136\/ard.60.4.316","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5601_CR64","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/BOR.0000000000000069","volume":"26","author":"N Yeremenko","year":"2014","unstructured":"Yeremenko N, Paramarta JE, Baeten D (2014) The interleukin-23\/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis. Curr Opin Rheumatol 26(4):361\u2013370. https:\/\/doi.org\/10.1097\/BOR.0000000000000069","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"5601_CR65","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361(9):888\u2013898. https:\/\/doi.org\/10.1056\/NEJMra0707449","journal-title":"N Engl J Med"},{"key":"5601_CR66","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485\u2013517. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132710","journal-title":"Annu Rev Immunol"},{"key":"5601_CR67","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3389\/fimmu.2018.01550","volume":"9","author":"MN van Tok","year":"2018","unstructured":"van Tok MN, Na S, Lao CR, Alvi M, Pots D, van de Sande MGH, Taurog JD, Sedgwick JD, Baeten DL, van Duivenvoorde LM (2018) The initiation, but not the persistence, of experimental spondyloarthritis is dependent on interleukin-23 signaling. Front Immunol 9:1550. https:\/\/doi.org\/10.3389\/fimmu.2018.01550","journal-title":"Front Immunol"},{"issue":"6","key":"5601_CR68","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/art.37937","volume":"65","author":"H Appel","year":"2013","unstructured":"Appel H, Maier R, Bleil J, Hempfing A, Loddenkemper C, Schlichting U, Syrbe U, Sieper J (2013) In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis. Arthritis Rheum 65(6):1522\u20131529. https:\/\/doi.org\/10.1002\/art.37937","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5601_CR69","first-page":"64","volume":"23","author":"M Ivanova","year":"2015","unstructured":"Ivanova M, Manolova I, Gancheva R, Boyadzhieva V, Stoilov R, Stanilova S (2015) Serum levels of IL-23 in ankylosing spondylitis and rheumatoid arthritis. Rheumatol (Bulgaria) 23(1):64\u201373","journal-title":"Rheumatol (Bulgaria)"},{"issue":"11","key":"5601_CR70","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Lin Z, Wei Q, Jiang Y, Gu J (2009) Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int 29(11):1343\u20131347. https:\/\/doi.org\/10.1007\/s00296-009-0883-x","journal-title":"Rheumatol Int"},{"key":"5601_CR71","first-page":"828","volume":"29","author":"C Romero-Sanchez","year":"2011","unstructured":"Romero-Sanchez C, Jaimes DA, Londono J, De Avila J, Castellanos JE, Bello JM, Bautista W, Valle-O\u00f1ate R (2011) Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis. Clin Exp Rheumatol 29:828\u2013834","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5601_CR72","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278(3):1910\u20131914. https:\/\/doi.org\/10.1074\/jbc.M207577200","journal-title":"J Biol Chem"},{"issue":"9","key":"5601_CR73","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen SL, Jain R, Garg AV, Cua DJ (2014) The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14(9):585\u2013600. https:\/\/doi.org\/10.1038\/nri3707","journal-title":"Nat Rev Immunol"},{"key":"5601_CR74","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3389\/fimmu.2018.02668","volume":"9","author":"A Watad","year":"2018","unstructured":"Watad A, Bridgewood C, Russell T, Marzo-Ortega H, Cuthbert R, McGonagle D (2018) The early phases of ankylosing spondylitis: emerging insights from clinical and basic science. Front Immunol 9:2668. https:\/\/doi.org\/10.3389\/fimmu.2018.02668","journal-title":"Front Immunol"},{"key":"5601_CR75","doi-asserted-by":"publisher","first-page":"1128270","DOI":"10.3389\/fimmu.2023.1128270","volume":"14","author":"RG van der Meer","year":"2023","unstructured":"van der Meer RG, Spoorenberg A, Brouwer E, Doornbos-van der Meer B, Boots AMH, Arends S, Abdulahad WH (2023) Mucosal-associated invariant T cells in patients with axial spondyloarthritis. Front Immunol 14:1128270. https:\/\/doi.org\/10.3389\/fimmu.2023.1128270","journal-title":"Front Immunol"},{"issue":"2","key":"5601_CR76","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233\u2013240. https:\/\/doi.org\/10.1084\/jem.20041257","journal-title":"J Exp Med"},{"issue":"7","key":"5601_CR77","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","volume":"10","author":"DJ Cua","year":"2010","unstructured":"Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10(7):479\u2013489. https:\/\/doi.org\/10.1038\/nri2800","journal-title":"Nat Rev Immunol"},{"key":"5601_CR78","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.3390\/ijms24076463","volume":"24","author":"S Del Vescovo","year":"2023","unstructured":"Del Vescovo S, Venerito V, Iannone C, Lopalco G (2023) Uncovering the underworld of axial spondyloarthritis. Int J Mol Sci 24:6463. https:\/\/doi.org\/10.3390\/ijms24076463","journal-title":"Int J Mol Sci"},{"key":"5601_CR79","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2741\/2667","volume":"13","author":"JJ Yu","year":"2008","unstructured":"Yu JJ, Gaffen SL (2008) Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 13:170\u2013177. https:\/\/doi.org\/10.2741\/2667","journal-title":"Front Biosci"},{"issue":"8","key":"5601_CR80","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9(8):556\u2013567. https:\/\/doi.org\/10.1038\/nri2586","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"5601_CR81","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen H, Goodall JC, Hill Gaston JS (2009) Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 60(6):1647\u20131656. https:\/\/doi.org\/10.1002\/art.24568","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5601_CR82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/rheumatology\/key001","volume":"57","author":"D Simone","year":"2018","unstructured":"Simone D, Al Mossawi MH, Bowness P (2018) Progress in our understanding of the pathogenesis of ankylosing spondylitis. Rheumatol (Oxf) 57(6):4\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/key001","journal-title":"Rheumatol (Oxf)"},{"issue":"5\u20136","key":"5601_CR83","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cytogfr.2011.09.004","volume":"22","author":"F Van Hauwermeiren","year":"2011","unstructured":"Van Hauwermeiren F, Vandenbroucke RE, Libert C (2011) Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1. Cytokine Growth Factor Rev 22(5\u20136):311\u2013319. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.09.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"5601_CR84","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev.med.45.1.491","volume":"45","author":"KJ Tracey","year":"1994","unstructured":"Tracey KJ, Cerami A (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491\u2013503. https:\/\/doi.org\/10.1146\/annurev.med.45.1.491","journal-title":"Annu Rev Med"},{"issue":"4","key":"5601_CR85","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.semarthrit.2004.08.005","volume":"34","author":"JC Davis","year":"2005","unstructured":"Davis JC (2005) Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum 34(4):668\u2013677. https:\/\/doi.org\/10.1016\/j.semarthrit.2004.08.005","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"5601_CR86","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38(4):499\u2013505. https:\/\/doi.org\/10.1002\/art.1780380407","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5601_CR87","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.59.6.404","volume":"59","author":"J Braun","year":"2000","unstructured":"Braun J, Sieper J (2000) Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies\u202f!? Ann Rheum Dis 59(6):404\u2013407. https:\/\/doi.org\/10.1136\/ard.59.6.404","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5601_CR88","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/rheumatology\/33.10.927","volume":"33","author":"J Gratac\u00f3s","year":"1994","unstructured":"Gratac\u00f3s J, Collado A, Filella X, Sanmart\u00ed R, Ca\u00f1ete J, Llena J, Molina R, Ballesta A, Mu\u00f1oz-G\u00f3mez J (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33(10):927\u2013931. https:\/\/doi.org\/10.1093\/rheumatology\/33.10.927","journal-title":"Br J Rheumatol"},{"issue":"12","key":"5601_CR89","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1136\/ard.2003.011023","volume":"62","author":"C Keller","year":"2003","unstructured":"Keller C, Webb A, Davis J (2003) Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review. Ann Rheum Dis 62(12):1128\u20131132. https:\/\/doi.org\/10.1136\/ard.2003.011023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5601_CR90","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13075-017-1490-y","volume":"19","author":"K Pavelka","year":"2017","unstructured":"Pavelka K, Kivitz A, Dokoupilova E, Blanco R, Maradiaga M, Tahir H, Pricop L, Andersson M, Readie A, Porter B (2017) Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3. Arthritis Res Ther 19(1):285. https:\/\/doi.org\/10.1186\/s13075-017-1490-y","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"5601_CR91","doi-asserted-by":"publisher","first-page":"e002165","DOI":"10.1136\/rmdopen-2021-002165","volume":"8","author":"J Braun","year":"2022","unstructured":"Braun J, Kiltz U, Deodhar A, Tomita T, Dougados M, Bolce R, Sandoval D, Lin CY, Walsh J (2022) Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST. RMD Open 8(2):e002165. https:\/\/doi.org\/10.1136\/rmdopen-2021-002165","journal-title":"RMD Open"},{"issue":"7","key":"5601_CR92","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/art.21913","volume":"54","author":"D van der Heijde","year":"2006","unstructured":"van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis, ATLAS Study Group (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54(7):2136\u20132146. https:\/\/doi.org\/10.1002\/art.21913","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5601_CR93","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002138","volume":"8","author":"D van der Heijde","year":"2022","unstructured":"van der Heijde D, Gensler LS, Maksymowych WP, Landew\u00e9 R, Rudwaleit M, Bauer L, Kumke T, Kim M, Auteri SE, Hoepken B, Deodhar A (2022) Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD Open 8(1):e002138. https:\/\/doi.org\/10.1136\/rmdopen-2021-002138","journal-title":"RMD Open"},{"issue":"11","key":"5601_CR94","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1093\/rheumatology\/kead112","volume":"62","author":"CLJ Weinstein","year":"2023","unstructured":"Weinstein CLJ, Sliwinska-Stanczyk P, H\u00e1la T, Stanislav M, Tzontcheva A, Yao R, Berd Y, Curtis SP, Philip G (2023) Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK). Rheumatol (Oxf) 62(11):3601\u20133609. https:\/\/doi.org\/10.1093\/rheumatology\/kead112","journal-title":"Rheumatol (Oxf)"},{"issue":"3","key":"5601_CR95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61","author":"J Sieper","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(3):8\u201318. https:\/\/doi.org\/10.1136\/ard.61.suppl_3.iii8","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5601_CR96","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/ar2642","volume":"11","author":"RJ Lories","year":"2009","unstructured":"Lories RJ, Luyten FP, De-Vlam K (2009) Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther 11(2):221. https:\/\/doi.org\/10.1186\/ar2642","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"5601_CR97","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/art.30393","volume":"63","author":"P Chiowchanwisawakit","year":"2011","unstructured":"Chiowchanwisawakit P, Lambert RG, Conner-Spady B, Maksymowych WP (2011) Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 63(8):2215\u20132225. https:\/\/doi.org\/10.1002\/art.30393","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5601_CR98","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1759720X12444175","volume":"4","author":"S Carter","year":"2012","unstructured":"Carter S, Braem K, Lories RJ (2012) The role of bone morphogenetic proteins in ankylosing spondylitis. Ther Adv Musculoskelet Dis 4(4):293\u2013299. https:\/\/doi.org\/10.1177\/1759720X12444175","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"5601_CR99","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/art.22372","volume":"56","author":"RJ Lories","year":"2007","unstructured":"Lories RJ, Derese I, de Bari C, Luyten FP (2007) Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 56(2):489\u2013497. https:\/\/doi.org\/10.1002\/art.22372","journal-title":"Arthritis Rheum"},{"key":"5601_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05463-7","author":"S Kleinert","year":"2023","unstructured":"Kleinert S, Schuch F, Rapp P, Ronneberger M, Wendler J, Sternad P, Popp F, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Wurth P, Sp\u00e4thling-Mestekemper S, Kuhn C, Vorbr\u00fcggen W, Welcker M (2023) Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-023-05463-7","journal-title":"Rheumatol Int"},{"key":"5601_CR101","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI23738","volume":"115","author":"RJU Lories","year":"2005","unstructured":"Lories RJU, Derese I, Luyten FP (2005) Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 115:1571\u20131579. https:\/\/doi.org\/10.1172\/JCI23738","journal-title":"J Clin Invest"},{"issue":"1","key":"5601_CR102","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/03009742.2017.1287305","volume":"47","author":"HT Liao","year":"2018","unstructured":"Liao HT, Lin YF, Tsai CY, Chou TC (2018) Bone morphogenetic proteins and Dickkopf-1 in ankylosing spondylitis. Scand J Rheumatol 47(1):56\u201361. https:\/\/doi.org\/10.1080\/03009742.2017.1287305","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"5601_CR103","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/03009740701774941","volume":"37","author":"MC Park","year":"2008","unstructured":"Park MC, Park YB, Lee SK (2008) Relationship of bone morphogenetic proteins to disease activity and radiographic damage in patients with ankylosing spondylitis. Scand J Rheumatol 37(3):200\u2013204. https:\/\/doi.org\/10.1080\/03009740701774941","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"5601_CR104","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3899\/jrheum.100200","volume":"37","author":"HA Chen","year":"2010","unstructured":"Chen HA, Chen CH, Lin YJ, Chen PC, Chen WS, Lu CL, Chou CT (2010) Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol 37(10):2126\u20132132. https:\/\/doi.org\/10.3899\/jrheum.100200","journal-title":"J Rheumatol"},{"key":"5601_CR105","doi-asserted-by":"publisher","first-page":"19185","DOI":"10.1074\/jbc.M414275200","volume":"280","author":"Y Tamamura","year":"2005","unstructured":"Tamamura Y, Otani T, Kanatani N, Koyama E, Kitagaki J, Komori T, Yamada Y, Costantini F, Wakisaka S, Pacifici M, Iwamoto M, Enomoto-Iwamoto M (2005) Developmental regulation of Wnt\/betacatenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem 280:19185\u201319195. https:\/\/doi.org\/10.1074\/jbc.M414275200","journal-title":"J Biol Chem"},{"key":"5601_CR106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle J, Sato AY, Bellido T (2017) Role and mechanism of action of sclerostin in bone. Bone 96:29\u201337. https:\/\/doi.org\/10.1016\/j.bone.2016.10.007","journal-title":"Bone"},{"issue":"11","key":"5601_CR107","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/art.24888","volume":"60","author":"H Appel","year":"2009","unstructured":"Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G (2009) Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 60(11):3257\u20133262. https:\/\/doi.org\/10.1002\/art.24888","journal-title":"Arthritis Rheum"},{"issue":"5","key":"5601_CR108","doi-asserted-by":"publisher","first-page":"R216","DOI":"10.1186\/ar4055","volume":"14","author":"CG Saad","year":"2012","unstructured":"Saad CG, Ribeiro AC, Moraes JC, Takayama L, Goncalves CR, Rodrigues MB, de Oliveira RM, Silva CA, Bonfa E, Pereira RM (2012) Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? Arthritis Res Ther 14(5):R216. https:\/\/doi.org\/10.1186\/ar4055","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"5601_CR109","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1136\/ard.2010.132852","volume":"69","author":"GR Heiland","year":"2010","unstructured":"Heiland GR, Zwerina K, Baum W, Kireva T, Distler JH, Grisanti M, Asuncion F, Li X, Ominsky M, Richards W, Schett G, Zwerina J (2010) Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis 69(12):2152\u20132159. https:\/\/doi.org\/10.1136\/ard.2010.132852","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5601_CR110","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/nyas.12968","volume":"1364","author":"W Xie","year":"2016","unstructured":"Xie W, Zhou L, Li S, Hui T, Chen D (2016) Wnt\/\u03b2-catenin signaling plays a key role in the development of spondyloarthritis. Ann N Y Acad Sci 1364(1):25\u201331. https:\/\/doi.org\/10.1111\/nyas.12968","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"5601_CR111","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/art.27231","volume":"62","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP (2010) Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62(1):150\u2013158. https:\/\/doi.org\/10.1002\/art.27231","journal-title":"Arthritis Rheum"},{"issue":"8","key":"5601_CR112","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","volume":"32","author":"SR Kwon","year":"2012","unstructured":"Kwon SR, Lim MJ, Suh CH, Park SG, Hong YS, Yoon BY, Kim HA, Choi HJ, Park W (2012) Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. Rheumatol Int 32(8):2523\u20132527. https:\/\/doi.org\/10.1007\/s00296-011-1981-0","journal-title":"Rheumatol Int"},{"issue":"7","key":"5601_CR113","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J, Gorman DM, Bowman EP, McClanahan TK, Yearley JH, Eberl G, Buckley CD, Kastelein RA, Pierce RH, Laface DM, Cua DJ (2012) IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells. Nat Med 18(7):1069\u20131076. https:\/\/doi.org\/10.1038\/nm.2817","journal-title":"Nat Med"},{"issue":"3","key":"5601_CR114","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/rheumatology\/kew384","volume":"56","author":"AA El-Zayadi","year":"2017","unstructured":"El-Zayadi AA, Jones EA, Churchman SM, Baboolal TG, Cuthbert RJ, El-Jawhari JJ, Badawy AM, Alase AA, El-Sherbiny YM, McGonagle D (2017) Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies. Rheumatol (Oxf) 56(3):488\u2013493. https:\/\/doi.org\/10.1093\/rheumatology\/kew384","journal-title":"Rheumatol (Oxf)"},{"issue":"1","key":"5601_CR115","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2021-222020","volume":"82","author":"JM Gwinnutt","year":"2023","unstructured":"Gwinnutt JM, Wieczorek M, Balanescu A, Bischoff-Ferrari HA, Boonen A, Cavalli G, de Souza S, de Thurah A, Dorner TE, Moe RH, Putrik P, Rodr\u00edguez-Carrio J, Silva-Fern\u00e1ndez L, Stamm T, Walker-Bone K, Welling J, Zlatkovi\u0107-\u0160venda MI, Guillemin F, Verstappen SMM (2023) 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis 82(1):48\u201356. https:\/\/doi.org\/10.1136\/annrheumdis-2021-222020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5601_CR116","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00296-023-05456-6","volume":"44","author":"L Paul","year":"2024","unstructured":"Paul L, McDonald MT, McConnachie A, Siebert S, Coulter EH (2024) Online physiotherapy for people with axial spondyloarthritis: quantitative and qualitative data from a cohort study. Rheumatol Int 44(1):145\u2013156. https:\/\/doi.org\/10.1007\/s00296-023-05456-6","journal-title":"Rheumatol Int"},{"issue":"4","key":"5601_CR117","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","volume":"18","author":"A Danve","year":"2022","unstructured":"Danve A, Deodhar A (2022) Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol 18(4):205\u2013216. https:\/\/doi.org\/10.1038\/s41584-022-00761-z","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"5601_CR118","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","volume":"77","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Sch\u00f6ls M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landew\u00e9 R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, Vlam K, van der Heijde D (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77(1):3\u201317. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211734","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5601_CR119","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41584-021-00656-5","volume":"17","author":"J Braun","year":"2021","unstructured":"Braun J, Baraliakos X, Kiltz U (2021) Treat-to-target in axial spondyloarthritis\u2014what about physical function and activity? Nat Rev Rheumatol 17(9):565\u2013576. https:\/\/doi.org\/10.1038\/s41584-021-00656-5","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"5601_CR120","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00296-021-05067-z","volume":"42","author":"S Maguire","year":"2022","unstructured":"Maguire S, Fitzgerald G, Gallagher P, O\u2019Shea F (2022) Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the Ankylosing Spondylitis Registry of Ireland (ASRI). Rheumatol Int 42(5):831\u2013838. https:\/\/doi.org\/10.1007\/s00296-021-05067-z","journal-title":"Rheumatol Int"},{"issue":"1","key":"5601_CR121","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landew\u00e9 RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, G\u00e9her P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, L\u00f3pez-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Comp\u00e1n V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5601_CR122","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/rheumatology\/keaa246","volume":"59","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ (2020) Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatol (Oxf) 59(4):47\u201357. https:\/\/doi.org\/10.1093\/rheumatology\/keaa246","journal-title":"Rheumatol (Oxf)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05601-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05601-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05601-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T02:02:48Z","timestamp":1724464968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05601-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":122,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["5601"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05601-9","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author Mariana Ivanova declares that she has no conflict of interest. Author Olena Zimba declares that she has no conflict of interest. Author Ivan Dimitrov declares that he has no conflict of interest. Author Alexander Angelov declares that she has no conflict of interest. Author Tsvetoslav Georgiev declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}